IP Library › Granted Patent US 11,820,787
Granted Patent B2
US 11,820,787 · App. 17/173,059 · Granted Nov 21, 2023

Benfotiamine derivatives in the treatment of alzheimer's disease

Inventors: Chunjiu Zhong (Shanghai, CN); Huan Zhang (Shanghai, CN)
Assignee: SHANGHAI RAISING PHARMACEUTICAL CO., LTD.
C07F9/6512
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,820,787
App. No.
17/173,059
Granted
Nov 21, 2023
Kind
B2
Abstract

The present disclosure relates to benfotiamine derivatives, a method for preparing the same and use of the benfotiamine derivatives in the manufacture of a medicament for the treatment of Alzheimer's disease.

Claims (2)

1. A method of treating Alzheimer's disease comprising administering a benfotiamine derivative to a subject in need thereof, wherein the benfotiamine derivative has a structure selected from the group consisting of:

2. The method according to claim 1 , wherein the benfotiamine derivative is formulated with a pharmaceutically acceptable carrier.

Assignments (2)
CHANGE OF NAME Recorded Aug 6, 2021
From: SHANGHAI RI XIN BIOTECHNOLOGY CO., LTD.
To: SHANGHAI RAISING PHARMACEUTICAL CO., LTD.
Reel/Frame 057114/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2021
From: ZHONG, CHUNJIU; ZHANG, HUAN
To: SHANGHAI RIXIN BIOTECHNOLOGY CO., LTD.
Reel/Frame 055220/0184 →
Continuity (2)
Division 16549700 · Aug 23, 2019
Related Publication 20210163515A1 · Jun 3, 2021